Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse

Annals of Neurology

Volumn 42, Issue 2, 1997, Pages 147-156

  Waterman, Sally A ^a   Lang, Bethan ^a   Newsom Davis, John ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CALCIUM CHANNEL; IMMUNOGLOBULIN G; OMEGA CONOTOXIN GVIA; OMEGA CONOTOXIN MVIIC;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EATON LAMBERT SYNDROME; FEMALE; HUMAN; IMMUNOPATHOGENESIS; MALE; MOTONEURON; MOUSE; NONHUMAN; PARASYMPATHETIC NERVE CELL; POSTGANGLIONIC NERVE; PRIORITY JOURNAL;

ACETYLCHOLINE; ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ANIMALS; AUTOANTIBODIES; AUTONOMIC NERVOUS SYSTEM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; FEMALE; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; LAMBERT-EATON MYASTHENIC SYNDROME; MALE; MICE; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE, SMOOTH; NEURONS; OMEGA-CONOTOXIN GVIA; OMEGA-CONOTOXINS; PEPTIDES; URINARY BLADDER; VAS DEFERENS;

EID: 0030755538     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410420204     Document Type: Article

References (50)

1. O'Neill JH, Murray NM, Newsom-Davis J. The Lambert-Eaton myasthenic syndrome. A review of 50 cases. Brain 1988; 111:577-596
2. Lang B, Newsom-Davis J. Immunopathology of the Lambert-Baton myasthenic syndrome. Springer Semin Immunopathol 1995;17:3-15
3. 2+ flux in a human small cell carcinoma line. Nature 1985;317:737-739
4. Fukunaga H, Engel AG, Osame M, et al. Paucity and disorganization of presynaptic membrane active zones in the Lambert-Eaton myasthenic syndrome. Muscle Nerve 1982;5:686-697
5. Fukunaga H, Engel AG, Lang B, et al. Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones. Proc Natl Acad Sci USA 1983;80:7636-7640
6. 2+ channels in mammalian central neurons. Trends Neurosci 1995;18:89-98
7. Lennon VA, Kryzer TJ, Griesmann GE, et al. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 1995;332:1467-1474
8. Leys K, Lang B, Johnston I, et al. Calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome. Ann Neurol 1991;29:307-314
9. Motomura M, Johnston I, Lang B, et al. An improved diagnostic assay for Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry 1995;58:85-87
10. Motomura M, Lang B, Johnston I, et al. The incidence of serum anti-P/Q-type and anti-N-type calcium channel antibodies in the Lambert-Eaton myasthenic syndrome. J Neurol Sci 1997 (In press)
11. Hong SJ, Chang CC. Inhibition of acetylcholine release from mouse motor nerve by a P-type calcium channel blocker, omega-agatoxin IVA. J Physiol (Lond) 1995;482:283-290
12. Sugiura Y, Woppmann A, Miljanich GP, et al. A novel ω-conopeptide for the presynaptic localization of calcium channels at the mammalian neuromuscular junction. J Neurocytol 1995;24:15-27
13. Heath JP, Ewing DJ, Cull RE. Abnormalities of autonomic function in the Lambert Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry 1988;51:436-439
14. Khurana RK, Koski CL, Mayer RF. Autonomie dysfunction in Lambert-Eaton myasthenic syndrome. J Neurol Sci 1988;85: 77-86
15. Rubenstein AE, Horowitz SH, Bender AN. Cholinergic dysautonomia and Eaton-Lambert syndrome. Neurology 1979;29: 720-723
16. McEvoy KM, Windebank AJ, Daube JR, et al. 3,4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome. N Engl J Med 1989;321:1567-1571
17. 2+ channels in neurotransmission in the rat urinary bladder. Br J Pharmacol 1995; 116:1595-1598
18. Hong SJ, Chang CC. Calcium channel subtypes for the sympathetic and parasympathetic nerves of guinea-pig atria. Br J Pharmacol 1995;16:1577-1582
19. Smith AB, Cunnane TC. ω-conotoxin GVIA-resistant neurotransmitter release in postganglionic sympathetic nerve terminals. Neuroscience 1996;70:817-824
20. Waterman SA. Multiple subtypes of voltage-gated calcium channel mediate transmitter release from parasympadietic neurons in the mouse bladder. J Neurosci 1996;16:4155-4161
21. Waterman SA. Role of N-, P- and Q-type voltage-gated calcium channels in transmitter release from sympathetic neurons in the mouse isolated vas deferens. Br J Pharmacol 1997;120: 393-398
22. Lang B, Newsom-Davis J, Wray D, et al. Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome. Lancet 1981;2: 224-226
23. Prior C, Lang B, Wray D, et al. Action of Lambert-Eaton myasthenic syndrome IgG at mouse motor nerve terminals. Ann Neurol 1985;17:587-592
24. Maggi CA. Nervous control of the urogenital system. Chur, Switzerland: Harwood Academic Publishers, 1993
25. Holzer P. Capsaicin: cellular targets, mechanisms of action and selectivity for thin sensory neurons. Pharmacol Rev 1991;43: 143-201
26. Maggi CA. Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves. Prog Neurobiol 1995;45:1-98
27. Kim YI, Neher E. IgG from patients with Lambert-Eaton syndrome blocks voltage-dependent calcium channels. Science 1988;239:405-408
28. Peers C, Lang B, Newsom-Davis J, et al. Selective action of myasthenic syndrome antibodies on calcium channels in a rodent neuroblastoma X glioma cell line. J Physiol (Lond) 1990; 421:293-308
29. Sher E, Biancardi E, Pollo A, et al. Omega-conotoxin-sensitive, voltage-operated Ca2+ channels in insulin-secreting cells. Eur J Pharmacol 1992;216:407-414
30. 2+ channels of human neuroblastoma IMR32 cells by Lambert-Eaton myasthenic syndrome (LEMS) IgGs. Neurosci Lett 1994;181:50-56
31. Johnston I, Lang B, Leys K, et al. Heterogeneity of calcium channel autoantibodies detected using a small-cell lung cancer line derived from a Lambert-Eaton myasthenic syndrome patient. Neurology 1994;44:334-338
32. El Far O, Marqueze B, Leveque C, et al. Antigens associated with N- and L-type calcium channels in Lambert-Eaton myasthenic syndrome. J Neurochem 1995;64:1696-1702
33. Viglione MP, O'Shaughnessy TJ, Kim YI. Inhibition of calcium currents and exocytosis by Lambert-Eaton syndrome antibodies in human lung cancer cells. J Physiol (Lond) 1995;488: 303-317
34. Zhao Y, Wein AJ, Levin RM. Role of calcium in mediating biphasic contraction of the rabbit urinary bladder. Gen Pharmacol 1993;24:727-731
35. Bourreau JP, Zhang ZD, Low AM, et al. Ryanodine and the adrenergic, purinergic stimulation in the rat vas deferens smooth muscle: functional and radioligand binding studies. J Pharmacol Exp Ther 1991;256:1063-1071
36. Lang B, Newsom-Davis J, Wray DW. The effect of Lambert-Eaton myasthenic syndrome antibody on slow action potentials in mouse cardiac ventricle. Proc R Soc Lond [Biol] 1988;235: 103-110
37. Zochodne DW. Autonomie involvement in Guillain-Barré syndrome: a review. Muscle Nerve 1994;17:1145-1155
38. Watkins PJ, Gayle C, Alsanjari N, et al. Severe sensoryautonomic neuropathy and endocrinopathy in insulindependent diabetes. Q J Med 1995;88:795-804
39. Pittenger GL, Liu D, Vinik AI. The neuronal toxic factor in serum of type 1 diabetic patients is a complement-fixing autoantibody. Diabetes Med 1995;12:380-386
40. Sundkvist G, Lind P, Bergstrom B, et al. Autonomie nerve antibodies and autonomic nerve function in type 1 and type 2 diabetic patients. J Intern Med 1991;229:505-510
41. Mitsumoto H, Schwartzman MJ, Estes ML, et al. Sudden death and paroxysmal autonomic dysfunction in stiff-man syndrome. J Neurol 1991;238:91-96
42. Fernandez A, Hontebeyrie M, Said G. Autonomie neuropathy and immunological abnormalities in Chagas' disease. Clin Auton Res 1992;2:409-412
43. Heafield MTE, Gammage MD, Nightingale S, et al. Idiopathic dysautonomia treated with intravenous gammaglobulin. Lancet 1996;347:28-29
44. Harik SI, Ghandour MH, Farah FS, et al. Postganglionic cholinergic dysautonomia. Ann Neurol 1977;1:393-396
45. Baron R, Engler F. Postganglionic cholmergic dysautonomia with incomplete recovery: a clinical, neurophysiological and immunological case study. J Neurol 1996;243:18-24
46. Takayama H, Kazahaya Y, Kashihara N, et al. A case of postganglionic cholinergc dysautonomia. J Neurol Neurosurg Psychiatry 1987;50:915-918
47. Lennon VA, Sas DF, Busk MF, et al. Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma. Gastroenterology 1991;100:137-142
48. Gerl A, Srorck M, Schalhorn A, et al. Paraneoplastic chronic intestinal pseudoobstruction as a rare complication of bronchial carcinoid. Gut 1992;33:1000-1003
49. Maitland CG, Scherokman BJ, Schiffman J, et al. Paraneoplastic tonic pupils. J Clin Neuro Ophthalmol 1985;5:99-104
50. Kusunoki S, Kanazawa I. Carcinomatous autonomie neuropathy and the autoantibodies in paraneoplastic neuropathy. Nippon Rinsho 1992;50:834-839